Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Acute lymphocytic leukemia (ALL) typically responds well to traditional chemotherapy. If ALL has certain features, targeted therapies, immunotherapy, and stem cell transplants may be considered.

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Sternal-marrow puncture showed a normal bone marrow, with only a slight increase of basophilic erythroblast ... Thus, each year 1 case of acute leukemia occurred among 20,000 people.

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...

The U.S. FDA has approved Autolus Therapeutics' Aucatzyl (obecabtagene autoleucel), a CD19-directed genetically modified ...

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. Some people live a long time with CMML, but others go on to develop acute myeloid leukemia (AML). Chronic myelomonocytic ...

Acute lymphoblastic leukemia/lymphoma (ALL), also called acute lymphocytic leukemia and acute lymphoid leukemia, is a type of blood cancer that starts with a change to a single cell in the bone marrow ...